Uncover key drivers, emerging technologies, and competitive movements shaping the multiomics services market from 2025–2034 with trusted insights from The Business Research Company

What Are The Future Growth Projections For The Multiomics Services Market Size?

The multiomics services market size has experienced substantial expansion in recent years. It is forecast to grow from $1.18 billion in 2024 to $1.42 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 20.6%. The historical growth of this market can be ascribed to the increasing availability of next-generation sequencing platforms, the expanded application of bioinformatics tools in research, the escalating demand for biomarker discovery, the proliferation of academic collaborations in systems biology, and the increasing applicability of multiomics in plant science.

The multiomics services market size is anticipated to undergo significant expansion in the coming years, reaching $2.96 billion by 2029 with a compound annual growth rate (CAGR) of 20.2%. This growth over the forecast period is fueled by the emergence of sustainable agriculture practices, a heightened emphasis on single-cell multiomics, the expanding application of spatial omics in disease research, the increasing demand for personalized nutrition, and the growing number of clinical trials utilizing multiomics. Noteworthy trends during this period include advancements in spatial transcriptomics tools, sophisticated microfluidics-enabled omics workflows, the development of real-time multiomics monitoring systems, innovations in cross-species multiomics applications, and the creation of wearable omics diagnostic technologies.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27355&type=smp

Which Demand Drivers Are Strengthening The Multiomics Services Market?

The multiomics services market is expected to expand moving forward due to the increasing adoption of personalized medicine. Personalized medicine is a medical approach that uses information about an individual’s genes and lifestyle to customize treatments and healthcare to their specific needs. This growing acceptance of personalized medicine is driven by people preferring health technologies that offer real-time monitoring and treatment plans tailored to their unique biology. Multiomics services further advance personalized medicine by integrating diverse biological data, including genomics, transcriptomics, proteomics, and metabolomics, to offer a comprehensive understanding of an individual’s health profile, thereby enabling tailored diagnosis, treatment, and disease prevention strategies. For instance, in February 2023, the Personalized Medicine Coalition, a US-based professional membership organization, reported that in 2022, 12 new personalized medicines were approved, representing approximately 34% of all newly approved therapies, which marked a substantial increase from previous years. Thus, the increasing adoption of personalized medicine is a key driver for the growth of the multiomics services market.

What Segmentation Insights Are Provided In The Multiomics Services Market Research?

The multiomics services market covered in this report is segmented

1) By Type: Single-Cell Multiomics, Bulk Multiomics

2) By Application: Biomarker Discovery, Drug Discovery And Development, Synthetic Biology, Other Applications

3) By End Users: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Other End Users

Subsegments:

1) By Single-Cell Multiomics: Single-Cell Genomics Services, Single-Cell Transcriptomics Services, Single-Cell Proteomics Services, Single-Cell Epigenomics Services

2) By Bulk Multiomics: Genomics And Transcriptomics Integration Services, Genomics And Proteomics Integration Services, Transcriptomics And Proteomics Integration Services, Epigenomics And Transcriptomics Integration Services

Which Notable Trends Are Transforming The Multiomics Services Market Outlook?

Leading companies within the multiomics services market are directing their efforts towards developing innovative methodologies, such as 3D genome mapping, to bolster understanding of gene regulation, disease mechanisms, and personalized treatment strategies. 3D genome mapping itself refers to the method of determining the three-dimensional spatial arrangement of the genome within a cell’s nucleus. For example, in January 2025, Enhanc3D Genomics, a biotechnology company based in the UK, launched a series of 3D multi-omics solutions designed to accelerate and improve the precision of drug discovery. These solutions provide unique functionalities, including the integration of genome-wide regulatory interaction data with multi-omics profiles in a single assay, thereby enabling comprehensive insights into gene regulation. Their proprietary Promoter Capture Hi-C technology permits the precise mapping of long-range interactions between regulatory elements and target genes, even those located in non-coding regions. The platform’s modular design, incorporating GenLinkConnect, GenLinkResponse, and GenLinkProfile, supports SNP-to-gene linkage, drug response analysis, and cell-specific regulatory profiling, respectively. Additionally, the GenLinkHub software delivers an intuitive interface for 3D visualization, data management, and quality control, ultimately enhancing researchers’ ability to interpret complex datasets and expedite drug discovery.

Which Firms Are Driving Innovation Within The Multiomics Services Market?

Major companies operating in the multiomics services market are Thermo Fisher Scientific Inc., Agilent Technologies Inc., PerkinElmer Inc., Bruker Corporation, QIAGEN NV, Azenta Inc., BGI Group, 10x Genomics Inc., BioLegend Inc., Oxford Nanopore Technologies Plc, NanoString Technologies Inc., Pacific Biosciences Inc., Metware Biotechnology Inc., Source BioScience Limited, CD Genomics Inc., Psomagen Inc., Creative Proteomics, Sapient Bioanalytics LLC, Dalton Bioanalytics Inc., and Clinical Microbiomics A/S.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/multiomics-services-global-market-report

Which Regional Markets Are Emerging As Key Hubs For The Multiomics Services Market?

North America was the largest region in the multiomics services market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the multiomics services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=27355&type=smp

Browse Through More Reports Similar to the Global Multiomics Services Market 2025, By The Business Research Company

Pet Insurance Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pet-insurance-global-market-report

Pet Healthcare Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pet-healthcare-global-market-report

Pet Diabetes Care Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pet-diabetes-care-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model